CPL-302-201

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameCPL-302-201

Drug Alias NameCPL-302-201

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors

TargetsPhosphatidylinositol 3 kinase delta

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelon Pharma Sa

China Registration ClassN/A

Active CompaniesCelon Pharma Sa

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A